Clinical Trial Update: Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab plus paclitaxel for recurrent/metastatic head and neck squamous cell carcinoma in patients unable to receive cisplatin. Resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• nivolumab (nivolumab)

Snippet

Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | Conditions: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-06-26